Patient Training About the Safety of Warfarin Therapy

Celal Bayar University

Status: Completed

Conditions: International Normalized Ratio Control; Patient Training; Warfarin Knowledge Level

Treatments: Other: training

Study type: Interventional

Funder types: Other

Identifiers

NCT02757482

CBU-2015-02

Details and patient eligibility

About

The purpose of this study is to examine the effects of patient training about the safety of warfarin therapy on related knowledge levels and on International Normalized Ratio (INR) control.

Full description

Although warfarin is widely used in the treatment and prophylaxis of thromboembolic diseases, it is an oral anticoagulant with serious adverse effects. Therefore, the patient must be informed about its safe use.

A patient's level of knowledge concerning the drug plays a key role in the effective and safe use of warfarin. In the Joint Commission International (JCI) National Patient Safety Goal (NPSG) guideline for 2014 education on treatment for patients taking oral anticoagulants was recognized as a vital factor. Previous studies have reported that a positive relationship between patients' anticoagulant knowledge levels and the INR number in the therapeutic range.

For this reason there is a need for effective education programs to increase patients' knowledge concerning warfarin and to keep it up to date. Education and information services provided to patients using anticoagulants will reduce the costs of treatment by reducing risks such as thromboembolism and bleeding. When planning education, individual characteristics and needs must be kept in mind, and group education in addition to individual sessions and the use of written and visual material will increase the effectiveness of the education.

Enrollment: 63 patients

Sex: All

Ages: 18 to 65 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Using warfarin for at least two months,
• Between 18 and 65 years old,
• Were literate,
• Not have a structured education about warfarin

Exclusion criteria

• Have structured education about warfarin,
• Have a seeing or hearing disability,
• Have a cognitive or sensory disorder,
• Have a disability affecting oral communication

Trial design

63 participants in 2 patient groups

intervention

Experimental group

Description:

Patient training

Treatment:

Other: training

control

No Intervention group

Description:

no patient training